VYOME HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
VYOME HOLDINGS, INC. (HIND) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of -$101.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2021-03-12
- VYOME HOLDINGS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2020 was -$101.00K.
- VYOME HOLDINGS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2019 was -$2.47M.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month |
|---|---|
| 2020-12-31 | -$101.00K 10-K · filed 2021-03-12 |
| 2019-12-31 | -$2.47M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |